V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005081 | 220018718 | null | 0 | Curative (C) | 2013-11-14 | 2013-11-14 | Trial Unspecified | Y | N | 220027410 | TRIAL |
| 220005082 | 220001994 | 1.66 | 80 | Curative (C) | 2016-04-20 | 2016-04-20 | Trial Unspecified | 1 | null | 220027417 | TRIAL |
| 220005083 | 220001995 | 1.73 | 86 | Palliative (P) | 2014-10-25 | 2014-11-18 | Cytarabine Low Dose | N | N | 220027420 | CYTARABINE |
| 220005084 | 220001995 | null | null | Palliative (P) | 2014-11-03 | 2014-11-04 | CYTARABINE | 1 | N | 220027420 | CYTARABINE |
| 220005085 | 220015909 | 1.72 | null | Palliative (P) | 2016-02-14 | 2016-02-18 | Cytarabine Low Dose | 2 | N | 220027423 | CYTARABINE |
| 220005086 | 220015909 | 1.7 | 0 | null | 2016-10-24 | 2016-10-24 | Cytarabine Low Dose | 02 | N | 220027423 | CYTARABINE |
| 220005087 | 220001996 | 1.7 | 91 | Disease modification (D) | 2016-11-28 | 2016-11-29 | Trial Unspecified | 01 | N | 220027430 | TRIAL |
| 220005088 | 220001996 | 1.67 | null | Palliative (P) | 2017-02-15 | 2017-02-27 | Cytarabine Low Dose | N | N | 220027430 | CYTARABINE |
| 220005089 | 220001997 | 1.92 | 57.5 | null | 2016-03-10 | 2016-03-22 | Cytarabine Low Dose | 02 | N | 220027432 | CYTARABINE |
| 220005090 | 220001997 | 1.68 | 66 | Not known (9) | 2016-03-23 | 2016-03-28 | Trial Unspecified | Y | N | 220027432 | TRIAL |
| 220005091 | 220001997 | 1.76 | 0 | Disease modification (D) | null | 2015-12-26 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027432 | CYTARABINE |
| 220005092 | 220001998 | null | 109.1 | Disease modification (D) | null | 2013-07-30 | Cytarabine Low Dose | N | null | 220027439 | CYTARABINE |
| 220005093 | 220001998 | 1.59 | 91 | Curative (C) | 2014-04-04 | 2014-04-05 | AML17 TRIAL | 01 | null | 220027439 | AML17 TRIAL |
| 220005094 | 220001998 | 1.82 | 60.7 | Curative (C) | 2016-06-22 | 2016-06-27 | AML17 TRIAL | Y | N | 220027439 | AML17 TRIAL |
| 220005097 | 220002000 | 1.86 | 51.2 | null | 2017-09-05 | 2017-09-05 | Trial Unspecified | Y | N | 220027450 | TRIAL |
| 220005098 | 220002001 | null | 67.599 | Curative (C) | 2017-02-26 | 2017-02-26 | AML17 TRIAL | 1 | N | 220027453 | AML17 TRIAL |
| 220005099 | 220002002 | null | 76.4 | Curative (C) | 2016-07-08 | 2016-07-14 | Trial Unspecified | Y | N | 220027456 | TRIAL |
| 220005100 | 220011056 | null | 60.3 | Curative (C) | 2015-11-07 | 2015-11-10 | AML17 TRIAL | N | N | 220027457 | AML17 TRIAL |
| 220005101 | 220011056 | 1.69 | 88.6 | Not known (9) | 2013-03-19 | 2013-03-19 | LI-1 TRIAL | Y | N | 220027457 | TRIAL |
| 220005102 | 220002003 | null | 97.6 | Palliative (P) | 2015-05-16 | 2015-05-30 | Trial Unspecified | N | N | 220027462 | TRIAL |
| 220005103 | 220011057 | 0 | 91 | Not known (9) | 2017-08-18 | 2017-08-18 | Trial Unspecified | 1 | null | 220027463 | TRIAL |
| 220005104 | 220002004 | null | 81.6 | Palliative (P) | 2014-04-22 | 2014-05-21 | Cytarabine Low Dose | N | N | 220027467 | CYTARABINE |
| 220005105 | 220002005 | 1.78 | null | Palliative (P) | 2014-09-29 | 2014-09-30 | Cytarabine Low Dose | N | N | 220027468 | CYTARABINE |
| 220005106 | 220002005 | 1.88 | 72.3 | Palliative (P) | 2015-11-26 | 2015-11-26 | Trial Unspecified | 1 | N | 220027468 | TRIAL |
| 220005107 | 220002006 | 1.82 | 86.9 | null | null | 2016-08-16 | Cytarabine Low Dose | N | N | 220027473 | CYTARABINE |
| 220005108 | 220002006 | 0 | 100.4 | Curative (C) | 2014-05-17 | 2014-05-17 | Trial Unspecified | Y | null | 220027473 | TRIAL |
| 220005109 | 220002006 | 1.75 | null | Palliative (P) | 2013-04-07 | 2013-04-12 | Cytarabine Low Dose | N | N | 220027473 | CYTARABINE |
| 220005110 | 220002007 | 1.65 | 65 | Curative (C) | 2015-01-15 | 2015-01-15 | AML17 TRIAL | Y | N | 220027481 | AML17 TRIAL |
| 220005111 | 220002007 | 1.59 | 78.6 | null | 2015-07-18 | 2015-07-18 | Trial Unspecified | 1 | N | 220027481 | TRIAL |
| 220005112 | 220015914 | 1.6 | 81.6 | Palliative (P) | 2014-11-13 | 2014-11-23 | CYTARABINE | 2 | null | 220027484 | CYTARABINE |
| 220005113 | 220002008 | 1.69 | null | Palliative (P) | 2017-12-18 | 2017-12-19 | Trial Unspecified | 1 | null | 220027485 | TRIAL |
| 220005114 | 220002009 | null | 96.2 | Curative (C) | 2014-05-30 | 2014-05-30 | AML17 TRIAL | Y | null | 220027489 | AML17 TRIAL |
| 220005115 | 220002009 | 1.68 | null | Palliative (P) | 2015-07-20 | 2015-07-20 | Cytarabine Low Dose | N | N | 220027489 | CYTARABINE |
| 220005116 | 220002009 | null | 61.1 | Curative (C) | 2013-02-20 | 2013-02-23 | LI-1 TRIAL | Y | null | 220027489 | TRIAL |
| 220005117 | 220002010 | null | 104 | Palliative (P) | null | 2015-01-01 | Cytarabine Low Dose | N | null | 220027493 | CYTARABINE |
| 220005118 | 220011062 | 1.58 | 0 | Palliative (P) | 2016-05-26 | 2016-05-29 | Cytarabine Low Dose | 02 | N | 220027497 | CYTARABINE |
| 220005119 | 220011062 | 1.56 | null | Curative (C) | 2016-12-13 | 2016-12-17 | Trial Unspecified | 01 | N | 220027497 | TRIAL |
| 220005120 | 220011062 | 1.57 | null | null | 2014-08-12 | 2014-08-25 | CYTARABINE | N | N | 220027497 | CYTARABINE |
| 220005121 | 220002011 | 1.58 | null | Palliative (P) | 2015-05-02 | 2015-05-08 | CYTARABINE | 2 | N | 220027501 | CYTARABINE |
| 220005122 | 220002011 | 1.52 | 84.25 | Curative (C) | null | 2014-11-18 | Cytarabine Low Dose | 2 | 2 | 220027501 | CYTARABINE |
| 220005123 | 220002011 | 1.91 | 62 | Curative (C) | null | 2013-04-10 | AML17 TRIAL | null | null | 220027501 | AML17 TRIAL |
| 220005124 | 220018721 | null | null | null | 2014-05-14 | 2014-05-14 | AML17 TRIAL | N | N | 220027511 | AML17 TRIAL |
| 220005125 | 220018721 | null | null | Curative (C) | 2013-08-16 | 2013-08-16 | AML17 TRIAL | 01 | N | 220027511 | AML17 TRIAL |
| 220005126 | 220002012 | null | 101.55 | Disease modification (D) | 2013-08-25 | 2013-08-31 | Trial Unspecified | Y | N | 220027516 | TRIAL |
| 220005127 | 220002013 | null | 72.6 | Palliative (P) | 2015-05-27 | 2015-05-27 | Trial Unspecified | 01 | N | 220027517 | TRIAL |
| 220005128 | 220002013 | 1.66 | 15.7 | null | 2017-03-23 | 2017-03-23 | LI-1 TRIAL | 01 | N | 220027517 | TRIAL |
| 220005129 | 220002014 | 1.75 | 72.6 | Not known (9) | 2013-08-12 | 2013-08-29 | LI-1 TRIAL | Y | N | 220027519 | TRIAL |
| 220005130 | 220002015 | 0 | null | Palliative (P) | null | 2015-08-18 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220027520 | CYTARABINE |
| 220005131 | 220002015 | 1.57 | 83.9 | null | 2014-03-31 | 2014-04-05 | Cytarabine Low Dose | 99 | null | 220027520 | CYTARABINE |
| 220005132 | 220002016 | 0 | 0 | Palliative (P) | 2013-06-05 | 2013-06-06 | CYTARABINE | 02 | N | 220027526 | CYTARABINE |